Meeting
2015 Gastrointestinal Cancers Symposium
Multicenter trial for assessing cytokine promoter gene polymorphism as a predictive parameter of PSK responder for curatively resected stage II or III colorectal cancer.
Authors
Shigefumi Yoshino
Digestive Surgey and Surgical Oncology, Yamaguchi University Graduate School of Medicine, Ube, Japan
Shigefumi Yoshino , Furuya Takumi , Koichiro Sakata , Ryoichi Shimizu , Naoko Okayama , Shoichi Hazama , Masaaki Oka
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Translational Research
Citation
J Clin Oncol 33, 2015 (suppl 3; abstr 619)
DOI
10.1200/jco.2015.33.3_suppl.619
Abstract #
619
Poster Bd #
C11
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Prognostic relevance of primary tumor sidedness in stage II/III colorectal cancer: An integrated analysis of JCOG0205, JCOG0404, JCOG0910, and JCOG1006 (JCOG2003A).
First Author: Akira Ouchi
Poster
2011 ASCO Annual Meeting
Follow-up after colorectal cancer surgery: Preliminary observational findings from the UK FACS trial.
First Author: J. N. Primrose
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Predicting recurrence using a tumor-uninformed ctDNA assay detecting MRD in patients with resected stage II or III colorectal cancer: Subset analysis from the GALAXY study in CIRCULATE-Japan.
First Author: Yoshiaki Nakamura
Poster
2023 ASCO Gastrointestinal Cancers Symposium
NSABP C-14: CORRECT-MRD II—Second colorectal cancer clinical validation study to predict recurrence using a circulating tumor DNA assay to detect minimal residual disease.
First Author: Mohamed E. Salem